Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Non-Current Debt (2016 - 2025)

Phibro Animal Health has reported Non-Current Debt over the past 13 years, most recently at $107.0 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $107.0 million for Q4 2025, down 6.14% from a year ago — trailing twelve months through Dec 2025 was $107.0 million (down 6.14% YoY), and the annual figure for FY2025 was $615.4 million, up 118.02%.
  • Non-Current Debt for Q4 2025 was $107.0 million at Phibro Animal Health, down from $609.5 million in the prior quarter.
  • Over the last five years, Non-Current Debt for PAHC hit a ceiling of $619.2 million in Q1 2025 and a floor of $95.0 million in Q2 2021.
  • Median Non-Current Debt over the past 5 years was $274.8 million (2022), compared with a mean of $274.6 million.
  • Biggest five-year swings in Non-Current Debt: plummeted 61.73% in 2024 and later skyrocketed 240.51% in 2025.
  • Phibro Animal Health's Non-Current Debt stood at $107.0 million in 2021, then surged by 71.96% to $184.0 million in 2022, then surged by 61.88% to $297.9 million in 2023, then plummeted by 61.73% to $114.0 million in 2024, then dropped by 6.14% to $107.0 million in 2025.
  • The last three reported values for Non-Current Debt were $107.0 million (Q4 2025), $609.5 million (Q3 2025), and $615.4 million (Q2 2025) per Business Quant data.